The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors-Reference-Cited by-同舟云学术

The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors

Published:2000-11 Issue:11 Volume:95 Page:3276-3281
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Ducreux Michel,Ruszniewski Philippe,Chayvialle Jean-Alain,Blumberg Joelle,Cloarec Denis,Michel Henri,Raymond Jean Michel,Dupas Jean-Louis,Gouerou Herve,Jian Raymond,Genestin Elisabeth,Hammel Pascal,Rougier Philippe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. Clinical review 72: diagnosis and management of functioning islet cell tumors

2. In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue

3. Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms;Therapeutic Advances in Medical Oncology;2024-01

2. Somatostatin Analogs and Interferon in the Treatment of Neuroendocrine Tumors;Neuroendocrine Tumours;2024

3. Non-Functioning Pancreatic Neuroendocrine Tumors;Neuroendocrine Tumours;2024

4. The Role of Receptor–Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors;Cancers;2023-12-25

5. Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases;Cancers;2023-08-08